AddBiomedtiek

AddBiomedtiek appears to be a South Korea-based biomedical diagnostics company referenced in public disclosures by ScreenPro/Justera Health as the Korean source company behind Add Biomedical's North American rights. The company is described as specializing in solutions for disease diagnosis and as having a product library that includes rapid screening tests. Publicly available evidence specifically links AddBiomedtiek to a CA 15-3 rapid breast cancer screening test and, indirectly through its North American commercialization partner, to broader diagnostic screening opportunities. The company does not appear to have a traditional therapeutic drug pipeline; instead, it seems to operate in in vitro diagnostics and screening technologies. Because direct primary company materials are limited and its website could not be independently accessed, several fields below are best treated as low-confidence approximations based on secondary references.